DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring nonapeptide first isolated from rabbit cerebral blood in 1977 by Swiss researchers Monnier and Schoenenberger. Named for its initial discovery in the context of delta-wave EEG sleep induction, subsequent research has identified DSIP as a multifunctional regulatory neuropeptide with roles in stress modulation, neuroendocrine regulation, and neuroprotection extending well beyond sleep. Below is a curated selection of peer-reviewed studies investigating its properties.
2021
Delta Sleep-Inducing Peptide Recovers Motor Function in SD Rats After Focal Stroke
PMC / Molecules (Open Access)
This study investigated intranasal DSIP administration over 8 days following experimentally induced focal stroke in rats. Treated animals demonstrated significant motor function recovery in rotarod testing compared to vehicle controls, and showed a trend towards reduced infarction volume, supporting DSIP’s potential neuroprotective applications in ischaemic injury models.
View Paper →2003
DSIP and Its Analogues Reduce Myocardial Infarction Area in Ischaemia-Reperfusion Models
PubMed / Peptides
This study demonstrated that DSIP and structurally related analogues reduced myocardial infarction area by approximately 32% in ischaemia-reperfusion injury models. The cardioprotective effects were consistent across multiple DSIP analogues, suggesting the core peptide sequence mediates protection against ischaemic tissue damage through regulatory mechanisms.
View Paper →1991
Antistressor Effect of Delta-Sleep-Inducing Peptide in Hypokinetic Stress
PubMed / Bulletin of Experimental Biology and Medicine
This study examined DSIP’s effects on neurotransmitter levels during experimentally induced hypokinetic stress in animals. DSIP administration normalised stress-induced changes in GABA, glutamate, aspartate, and homocarnosine, and restored GABA metabolism enzyme activity, demonstrating a direct neuroprotective anti-stress mechanism.
View Paper →1984
Characterisation, Properties and Multivariate Functions of Delta-Sleep-Inducing Peptide
PubMed / Neuropsychobiology
This foundational review by the peptide’s discoverers documents DSIP’s multivariate biological activity, including its interaction with acute and chronic stress, modulation of MAO-A and RNA synthesis in the brain, neuroendocrine regulatory effects, and electrophysiological actions on isolated neurons. It established DSIP as a broad-spectrum regulatory neuropeptide rather than solely a sleep factor.
View Paper →1981
The Influence of Synthetic DSIP on Disturbed Human Sleep
PubMed / European Journal of Pharmacology
This human clinical study administered synthetic DSIP intravenously to chronic insomniacs. Treatment produced longer sleep duration, higher sleep quality with fewer interruptions, slightly more REM sleep, and no daytime sedation or adverse effects. The results demonstrated DSIP’s normalising influence on human sleep regulation in a clinical population.
View Paper →1978
Delta Sleep-Inducing Peptide: A Multifunctional Neuropeptide — Original Characterisation
PubMed / Nature
The foundational paper identifying and characterising DSIP, reporting that intravenous administration produced hours of sleep in multiple animal species. The study documented DSIP’s structure-activity relationships and established the basic pharmacological framework for all subsequent research, placing DSIP among the first sleep-regulatory peptides identified in mammals.
View Paper →